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warranted to determine their role in risk stratification strategies.
Table. Patient characteristics
Variable No. (%) or mean (N  697)
Age group, years
44-55 206 (30)
56-65 336 (48)
66-74 155 (22)
Current smoker 48 (7)
Diabetes mellitus 49 (7)
Hypertension 261 (38)
Hyperlipidemia 330 (48)
Peripheral vascular disease 32 (4.7)
Stroke 13 (1.9)
Angiographic CAD 22 (3.47)
Body mass index, kg/m2 29.7
CAD, Coronary artery disease
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Objective(s): Thrombospondin-1 (TSP-1) is a matricellular glyco-
protein released from platelets at sites of arterial injury. After angioplasty,
TSP-1 plays a role in the formation of the neointima. MicroRNAs (miR)
are small noncoding RNAs that traditionally function by binding target
gene messenger RNA and inhibiting protein translation. Previous study
has shown that miR-21 is upregulated after angioplasty, and inhibition of
miR-21 leads to decreased intimal hyperplasia. In this study, we exam-
ined the acute effects of miR-21 inhibition on vascular smooth muscle
cells (VSMCs).
Methods: Quiescent VSMCs were treated for 20 minutes with 25
nM miR-21 inhibitor. Migration toward TSP-1 (20 g/mL) or the
negative control, serum-free media (SFM) was assessed using a modified
Boyden microchemotaxis chamber. Quiescent VSMCs were acutely
treated with the miR-21 inhibitor and then exposed to TSP-1 or basal
media. Protein was collected, and phosphorylated extracellular signaling
kinase (pERK) 1/2 expression was assessed by Western blot. Densitom-
etry was converted to percent positive control. Quantitative real-time
polymerase chain reaction (qRT-PCR) for TSP-1, hyaluronic acid syn-
thase 2 (HAS2), and transforming growth factor-	2 (TGF-	2)was performed
on samples acutely treated with miR-21 inhibitor before a 6-hour exposure to
TSP-1. Statistical analysis was performedusing analysis of variancewith post hoc
testing. Significancewas set atP .05.Comparisons formigration andWestern
blots were made to positive control.
Results: TSP-1 increased VSMC migration compared with serum-free
media alone (100%  9.6% vs 43.7%  7.4%). miR-21 inhibitor treatment
reduced VSMCmigration to levels comparable to negative control (44.8%
4.9%). TSP-1 increased pERK 1/2 compared with basal media (p42:
100%  0% vs 78.6%  6.4%; p44: 100%  0% vs 76.2%  2.3%). miR-21
inhibition returned pERK to levels comparable with basal media (p42:
77%  6.2%; p44: 71%  9.8%). miR-21 inhibition had no effect on
TSP-1–stimulated expression of TSP-1, HAS2, or TGF-	2 (P  .05).
Conclusions: Acute inhibition of miR-21 leads to a functional
decrease in VSMC migration toward TSP-1. Additionally, acute inhibi-
tion of miR-21 decreased activated ERK 1/2, indicating a direct role for
miR-21 in the TSP-1 signaling cascade. However, miR-21 does not
acutely affect HAS2, TSP-1, or TGF-	2 gene expression. These data
indicate that miR-21 may directly modulate cell functions and signaling
pathways in ways other than by inhibition of protein translation.
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Objective(s): This study evaluated the effect on intimal hyperplasia of
intraperitoneal (IP) administration of the phytochemicals resveratrol, allicin,
sulforaphane (SFN) and epigallocatechin-3-gallate (ECGC) in the murine
carotid artery injury model.
Methods: Myointimal hyperplasia (MIH) was induced in carotid ar-
teries of 27 rats by introduction of a wire with a diameter near that of the
artery (
0.2 mm.). The control group (n  5) was injected with saline,
whereas the experimental groups were injected daily with the corresponding
phytochemical. Intima-to-media ratios (IMR) were quantified on 2-week spec-
imens from photomicrographs using J software (National Institutes of Health,
Bethesda, MD). Statistical significance was measured by the Student t test.
Results: IP injections of phytochemical suppressed intimal hyperplasia in
rat carotid arteries at 2 weeks compared with controls and is summarized in the
Table. Further studies performed in the EGCG group consisted of Ki-67
proliferation indices and analysis of extracellular signal-regulated kinase, c-Jun
N-terminal kinases, and p-38 expression. Ki-67 index was significant reduced in
EGCG animals (3.3 1.0) compared with controls (6.2 1.3). Extracellular
signal-regulated kinase expression was similar suppressed in the EGCG group.
No change were noted for c-Jun N-terminal kinases and p-38 expression.
Conclusion: Intraperitoneal injection of the phytochemical ECGC has
significant suppressive effects on the development of myointimal hyperplasia in
our carotid artery injury model. Other phytochemicals showed lesser effects.
Table.
Study group
dose
Dose
(g) MIH (mm2)
Reduction
of control
(%) P IMR
Reduction
of control
(%) P
Control 0.22  0.03 0.70  0.08
Allicin 15 0.12  0.02 44 .05 0.41  0.05 40 .05
Resveratrol 18 0.09  0.03 50 .05 0.36  0.09 49 .05
Sulforaphane 0.48 0.09  0.03 57 .05 0.30  0.09 57 .01
EGCG 10 0.8  0.03 63 .05 0.20  0.05 72 .01
EGCG, Epigallocatechin-3-gallate; IMR, intima-to-media ratios; MIH,
myointimal hyperplasia.
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Objective(s): Vascular endothelial growth factor (VEGF) stimulates
angiogenesis and determines arterial identity in embryonic endothelial
cells (ECs). When vein grafts are placed into arterial circulation, VEGF
expression transiently increases; yet, later time points find its expression
to be ultimately decreased. As such, the role of VEGF in normal vein graft
adaptation to the arterial environment is not clear, and its role in adult
EC phenotypic regulation remains unknown. Accordingly, we examined
the role of VEGF in modulating phenotypic changes in adult venous ECs.
Methods: Adult mouse lung endothelial cells (MLECs) were stimu-
lated with 100 ng/mL VEGF-A165 for 0 to 24 hours. In some experiments,
cells were pretreated for 1 hour with VEGF receptor 2 (R2) neutralization
antibody (1 g/mL) or VEGFR2 kinase inhibitor (100 nM) before
VEGF-A stimulation. EphB4, Ephrin-B2, delta-like ligand 4 (Dll4), neuro-
pilin-1, and neuropilin-2 expression were examined using real-time quanti-
tative polymerase chain reaction.
Results: At baseline, adult MLECs display a venous phenotype and are
EphB4-positive and Ephrin-B2-negative. VEGF treatment resulted in
downregulation of the venous marker EphB4 in a time-dependent (n  8,
P .0003) and dose-dependent (n 3, P .05) manner. VEGF treatment
increased expression of Dll4 in a time-dependent manner (n  8; P  .0001)
but did not affect Ephrin-B2 (n 8, P .05). Neruropilin-1 and neuropilin-2
expression were transiently increased at 1 hour and decreased by 24 hours (n
8; P .0001). Pretreatment with VEGFR2 neutralizing antibody or VEGFR2
kinase inhibitor inhibited EphB4 downregulation and the early increased ex-
pression of neuropilin-2 but did not affect the upregulation of Dll4 (n 3, P
.3276) nor the early increased expression of neuropilin-1.
Conclusions: In adult venous ECs, VEGF inhibits expression of ve-
nousmarker EphB4 and stimulates expression of arterial marker Dll4. VEGF
regulation of EphB4 is mediated by VEGFR2. Our results suggest that
regulation of Dll4 is independent of VEGFR2might be through an alternate
pathway. The finding that arterial marker Ephrin-B2 is not increased by
VEGF treatment is consistent with our prior work showing that vein graft
adaptation results in loss of venous EphB4 identity without a gain of arterial
Ephrin-B2 identity. Vein graft adaptation to the arterial environment may
depend on the plasticity of adult ECs and their ability to integrate VEGF
signaling pathways to properly modify vessel phenotype.
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